NAVIDEA BIOPHARMACEUTICALS, INC. - NAVBQ

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2023 · Q2 2023
Value (USD)
Total reported value ($000)
$113K
QoQ value delta ($000)
+$25K (+28.41%)
Implied price effect (QoQ)
-0.11%
Shares
Total shares
1,310,041
QoQ shares delta
+290,998 (+28.56%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (NAVBQ)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2023)

Top 25 only Full list
Early Q4 2025 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
STATE STREET CORP 37 412,743 0.0%
GEODE CAPITAL MANAGEMENT, LLC 33 368,830 0.0%
VANGUARD GROUP INC 24 276,491 0.0%
UBS Group AG 13 149,612 0.0%
NORTHERN TRUST CORP 3 39,414 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 3 40,000 0.0%
JPMORGAN CHASE & CO 0 1,300 0.0%
BANK OF AMERICA CORP /DE/ 0 1,604 0.0%
WELLS FARGO & COMPANY/MN 0 5,632 0.0%
MORGAN STANLEY 0 4,416 0.0%
GROUP ONE TRADING, L.P. 0 300 0.0%
Tower Research Capital LLC (TRC) 0 8,937 0.0%
NewEdge Advisors, LLC 0 412 0.0%
Parallel Advisors, LLC 0 350 0.0%